• Home
  • Agenda
  • Speakers
  • Partners
    • Commercial Partners
    • Media Partners
    • Become a Commercial Partner
    • Host a webinar
  • Summit Details
    • Venue & Accommodation
    • FAQS
    • Sign up for conference updates
    • Contact Us
  • Attendance
    • Why attend
    • Gallery
    • Audience Breakdown
    • Poster Competition
    • Ticket details
  • DDF Summits
    • DDF Global
    • DDF Asia
  • LOG IN
  • Book now
Nanoform
nanoform.com

Nanoform is an innovative nanoparticle medicine-enabling company that works together with global Pharma and biotech partners to devise solutions to complex formulation challenges. Nanoform’s multi-patented and scalable Controlled Expansion of Supercritical Solutions (CESS®) process can produce uniform nanoparticles as small as 10nm, facilitating transport even across biological barriers. As particles smaller than 100nm have significantly enhanced surface areas, this can increase drug dissolution rates and improve bioavailability, allowing drugs of poor solubility in the pharmaceutical pipeline to progress to clinical development. CESS® enables lower dosage and safer products to be developed with reduced side-effects and permits combination therapies, which would otherwise be prohibited by the large dosages of either drug. The award-winning technology is also ushering in a new era of ocular, pulmonary and transdermal drug delivery applications, along with enhanced delivery of drug particles across the blood-brain barrier.

Back

Information


Mark Allen Group
St Jude’s Church
Dulwich Road
London
SE24 0PB
United Kingdom

Main reception at Publication company: +44 (0)20 7738 5454


Additional Enquiries:


Alexandra Krcho, Account Director +44 (0)20 3874 9205
Adrian Forde, Delegate Sales Director + 44 (0)20 3874 9209

[Privacy Policy] – Please read our privacy policy to understand how we process, use, and safeguard your data.

Further information


Privacy policy

Cookie policy

Terms and conditions

Booking terms and conditions